PALI
Palisade Bio
$1.19
−$0.01 (−0.83%)Oct 28, 2026
Key metrics
The numbers that frame PALI today
- Market cap
- $207.38M
- Gross margin
- 100%
- EV / Sales
- 164.3
- ROIC
- 956.5%
- Div yield
- 0%
- Debt / equity
- 0.0
- 52wk Low
- $1.10
- 52wk High
- $2.86
Growth
Revenue and earnings trend for PALI
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about PALI
Is Palisade Bio a good buy?
No. Palisade Bio has poor quality and poor momentum. Both signals point to a weaker setup. Growth looks mixed. The support signal is useful, but not decisive. We think Palisade Bio is selling at a very high price.
What is the market capitalization of PALI?
Palisade Bio's market capitalization is $207.38M.
What is the 52-week high for PALI stock?
The 52-week high for Palisade Bio is $2.86. The current close of $1.19 is 58.3% below that high.
What is the 52-week low for PALI stock?
The 52-week low for Palisade Bio is $1.10. The current close of $1.19 is 8.2% above that low.
Does PALI stock pay dividends?
Palisade Bio does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for PALI?
Palisade Bio's Debt / Equity ratio is 0.